文献速递冠心病外科瓣膜外科

常规局部应用杆菌肽预防心脏术后胸骨伤口感染

Routine Use of Topical Bacitracin to Prevent Sternal Wound Infections After Cardiac Surgery.
PubMed 文献 · Ann Thorac Surg · 2017-07-12

该单中心回顾性研究纳入2006至2015年1495例冠脉搭桥和瓣膜手术患者,所有患者术前静脉抗生素并按常规在皮肤缝合后胸骨切口局部涂抹杆菌肽软膏。9年间无深部胸骨伤口感染发生,预测率为0.29%(IQR 0.19%-0.46%),仅4例浅表感染,患者耐受良好无严重不良反应。

要点

  • 心脏术后胸骨切口局部涂抹杆菌肽软膏安全,未报告严重不良反应。
  • 9年1495例冠脉搭桥和瓣膜手术中无深部胸骨伤口感染发生。
  • 仅4例浅表胸骨伤口感染,多数培养为革兰阳性菌。

核心结论

  • 心脏手术后胸骨手术皮肤切口常规局部应用杆菌肽是安全的。
  • 研究期间未观察到深部胸骨伤口感染。
  • 该简单干预可能作为预防胸骨伤口感染的有用辅助策略。

研究设计与样本

  • 单中心回顾性研究,纳入2006至2015年所有冠脉搭桥和瓣膜手术病例共1495例。
  • 所有患者接受适当的术前静脉抗生素,并在皮肤缝合后常规于胸骨手术切口局部涂抹杆菌肽软膏。
  • 评估胸骨伤口感染发生率,并与胸外科医师学会国家数据库风险计算器的预测率比较。

主要发现

  • 9年间未观察到深部胸骨伤口感染,预测率为0.29%(四分位距0.19%至0.46%)。
  • 观察到4例浅表胸骨伤口感染,多数病例培养出革兰阳性菌。
  • 患者对杆菌肽软膏耐受良好,未报告严重不良效应。

临床怎么用

  • 在心脏冠脉搭桥和瓣膜手术后,可考虑在皮肤缝合后于胸骨切口局部涂抹杆菌肽软膏作为辅助预防措施。
  • 该干预简便、易得且廉价,但需结合术前静脉抗生素等标准预防措施。

局限性

  • 为单中心回顾性研究,未设对照组,证据级别有限。
  • 深部感染为零可能与样本量及随访方式有关,需更高质量研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The development of sternal wound infections remains a serious complication after cardiac surgery. A number of studies have assessed the use of topical antibiotics placed on the sternal edges. We evaluated the routine use of bacitracin ointment applied over the sternotomy skin incision as a prophylactic measure against sternal wound infections. METHODS: A retrospective review of all coronary artery bypass graft and valve surgery cases performed at a single institution between 2006 and 2015 was performed (n = 1,495). Appropriate preoperative intravenous antibiotics were administered for all patients. Bacitracin topical antibiotic ointment was routinely applied to the sternal surgical incision after skin closure for all patients during this period. The incidence of sternal wound infection was assessed. RESULTS: During this 9-year experience, no episodes of deep sternal wound infections were observed, compared with a predicted rate of 0.29% (interquartile range: 0.19% to 0.46%) based on The Society of Thoracic Surgeons National Database risk calculator. Four episodes of superficial sternal wound infections were noted; gram-positive organisms were cultured in the majority of these cases. Bacitracin ointment was well tolerated by patients, with no serious adverse effects reported. CONCLUSIONS: This study suggests that the routine application of topical bacitracin over the surgical skin incision is safe after cardiac surgery. Deep sternal wound infections were notably absent during this period. As a readily available and inexpensive therapy, this simple intervention may be a useful adjunct strategy in preventing sternal wound infections.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Chan JL, Diaconescu AC, Horvath KA, et al. Routine Use of Topical Bacitracin to Prevent Sternal Wound Infections After Cardiac Surgery. Ann Thorac Surg. 2017. PMID: 28709667. doi:10.1016/j.athoracsur.2017.04.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。